Description
Retatrutide is a peptide acting as a triple receptor agonist for GLP-1 receptors (GLP-1R), GIP receptors (GIPR), and glucagon receptors (GCGR). It enhances insulin secretion by activating GLP-1R, inhibits glucagon release, delays gastric emptying, and increases satiety; activates GIPR to enhance insulin sensitivity and regulate lipid metabolism; activates GCGR to promote energy expenditure, inhibit hepatic gluconeogenesis, and reduce hepatic fat deposition. This multi-target synergistic action makes it superior to traditional single-target GLP-1 drugs in lowering blood glucose, reducing body weight, and improving hepatic fat deposition.
The peptide will be provided as lyophilized powder to ensure maximum stability.
Reviews
There are no reviews yet.